Vladimir Skljarevski, based in Indianapolis, Indiana, United States, is currently a Executive Medical Director at Cortexyme Inc., bringing experience from previous roles at Eli Lilly and Company. Vladimir Skljarevski holds a 2013 - 2017 University of Vermont. With a robust skill set that includes Clinical Trials, Medical Writing, CRO, Neuroscience, Medical Education and more, Vladimir Skljarevski contributes valuable insights to the industry.